Logo-bi
Bioimpacts. 2025;15: 30996 | Published on: 2025 Aug 27. doi: 10.34172/bi.30996

Review

Revolutionizing cancer therapy: Monoclonal antibodies in radiosensitization

Abolfazl Bemidinezhad 1,2,3, Yasaman Abolhassani 4, Mojgan Noroozi-Karimabad 1, Arman Abroumand Gholami 5, Abbas Alalikhan 3,6,7, Ramin Roshani 8, Mohammad Parsa-kondelaji 9, Fatemeh Gheybi 4,10 * ORCID

Cited by CrossRef: 0



As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons